Symbol="ABCL"
AssetType="Common Stock"
Name="Abcellera BiologicsÂ Inc"
Description="AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada."
CIK="1703057"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2215 YUKON STREET, VANCOUVER, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2249191000"
EBITDA="-43953000"
PERatio="None"
PEGRatio="None"
BookValue="4.19"
DividendPerShare="0"
DividendYield="0"
EPS="-0.18"
RevenuePerShareTTM="0.633"
ProfitMargin="-0.277"
OperatingMarginTTM="-0.405"
ReturnOnAssetsTTM="-0.0297"
ReturnOnEquityTTM="-0.0415"
RevenueTTM="181035000"
GrossProfitTTM="311109000"
DilutedEPSTTM="-0.18"
QuarterlyEarningsGrowthYOY="0.459"
QuarterlyRevenueGrowthYOY="-0.961"
AnalystTargetPrice="26.5"
TrailingPE="-"
ForwardPE="27.47"
PriceToSalesRatioTTM="4.933"
PriceToBookRatio="2.318"
EVToRevenue="3.491"
EVToEBITDA="5.61"
Beta="-0.145"
num_52WeekHigh="14.97"
num_52WeekLow="5.53"
num_50DayMovingAverage="6.99"
num_200DayMovingAverage="8.97"
SharesOutstanding="288728000"
DividendDate="None"
ExDividendDate="None"
symbol="ABCL"
open="7.79"
high="7.89"
low="7.51"
price="7.52"
volume="1101890.00"
latest_trading_day="2023-07-27"
previous_close="7.76"
change="-0.24"
change_percent="-3.0928%"
aroon_positive_momentum_days="21"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="2530045"
Change_recent_avg="-0.02"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="104"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0072.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="670"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_positive_thumbnail_id_2="1010"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0172.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
